UK insurtech fundraising has become more disciplined since the early-2020s peak. Investors have learned that unit economics, underwriting discipline and regulatory navigation matter more than growth alone. But the category remains strongly funded — particularly for platforms serving incumbents or targeting underserved specialty insurance markets.
A venture capital firm is a professional fund that invests pooled capital into high-growth startups in exchange for equity. Unlike angels investing their own money, VCs deploy capital on behalf of LPs — institutional investors, family offices and corporates. That shapes how they make decisions, the cheque sizes they write and the returns they expect.
UK insurtech VC cheques typically range from £500k to £7m at early stages, with rounds from £1m to £15m. Diligence runs four to ten weeks with attention to loss ratios, combined ratio, distribution model, regulatory positioning (FCA, PRA) and partner engagement with underwriters or reinsurers.
Not every VC is the right VC for InsurTech. When building a shortlist, compare them on:
Relevance beats reach. A sector-aligned VC will move faster, ask sharper questions and bring more than capital.
UK insurtech capital has concentrated in specialist fintech and insurtech VCs. Generalist funds have become cautious after several high-profile stumbles. Aligned investors move faster and price insurance risk more accurately.
Fit starts before the first meeting. Check each VC's recent investments, whether they led or followed and how portfolio founders describe the partnership post-close. Warm intros still matter — but the best ones come from shared context, not generic requests. A tight list of ten aligned VCs will outperform scattered outreach to fifty every time, especially in a tougher funding environment.
The right insurtech VC will help navigate regulation, sharpen unit economics and open the distribution and underwriting relationships that define commercial success in insurance.
1818 is an innovative Venture Capital firm focused on early and growth stage digital technology companies. Typically, we are amongst the first to invest, and we always personally invest in everything we do.
We partner with companies that have significant growth potential, and founders who have the vision, determination and commitment to achieve it. Providing capital is the first step of what we do. With a team comprised of entrepreneurial and motivated individuals, we serve an active role in our portfolio companies to ensure each business thrives to deliver the best possible results for our investors.
1818 Venture Capital was founded in Guernsey in 2012. We are independently owned and operated.
When we founded AlbionVC in 1996 we set out to partner with visionary entrepreneurs to create successful companies across a range of industries.
A lot has changed since, however the way we do business has not. We are supportive investors, not operators, who strive for excellence and show ethics and humility in our interactions with founders and with each other.
We invest in startups with potential to grow into enduring companies that reshape industries. In doing so we achieve top quartile returns for our investors.
Today we focus on the software, healthcare and deeptech in the UK. The knowledge and insights we have built up over the last 29 years have given us an ability to spot companies that are set to become global category leaders. And have shaped our understanding of the tools & support we can offer them on their journey.
All of this is only possible because of the long term, considerate yet high performing culture, embodied by an inspiring team, half of whom have been doing this for well over a decade.
Since 1997, Amadeus Capital Partners has backed more than 190 pioneering companies and raised over $1.3 billion to fuel their growth. We’re a team of investors and entrepreneurs driven by curiosity, partnership, and the transformative power of technology.
We invest in trailblazers – founders turning bold ideas into global impact. Our portfolio spans breakthrough businesses such as Cryptosense, the global leader in cryptography management software (acquired by SandboxAQ); Igenomix in reproductive genetics (acquired by EQT); CSR’s single-chip Bluetooth innovation (acquired by Qualcomm); and VocalIQ, a speech recognition company (acquired by Apple).
From intelligence and human potential to the future of the planet, we back deep tech companies redefining what’s possible.
At Black Seed, we champion inclusion, addressing the historical underfunding and over-mentoring of Black British founders. With only 0.24% of venture funding reaching this community in the past decade, we seize the opportunity to invest in diverse talent. We bring capital, connections and empower exceptional individuals. As both a Fund and a Community, we holistically support Black founders, fusing technology, culture, empathy and innovation to foster a more diverse & inclusive entrepreneurial landscape.
At Exceptional Ventures, our motto is Believing in Believers. We believe that innovative businesses can make the world a better place, and we believe in entrepreneurs that feel the same. It is our mission to support them with our expertise and capital, and to help them build a better future.We focus on businesses that are helping people live healthier, happier, longer lives. Our portfolio ranges from sustainable consumer products to applications focused on mental and physical health, and on the future of foods. We have extensive experience and networks across Europe that we have built while running and investing in some of Europe’s most successful businesses. We have over 50 years of combined expertise across the sectors of focus and a portfolio of over 160 startups.
We are uniquely able to access the most talented entrepreneurs building the most progressive companies and are building a portfolio of 40 exceptional businesses in our first fund. We offer extensive support to companies early in their journeys with our capital, network, and advice.By bringing together passionate investors and world-class entrepreneurs, our mission is to improve the length and quality of human lives, while helping to build a sustainable planetary ecosystem.
